glp-1 aspiration drugs and risk MHRA warns of pulmonary aspiration

Yabe et al

While body weight and metabolic phenotypes remain the primary endpoints, the outcome spectrum is progressively extending toward lipotoxic load [e.g., hepatic fat and visceral adipose tissue (VAT)], inflammatory/cardiometabolic risk markers, and reproductive outcomes with higher clinical decision-making value, such as menstruation, ovulation, and pregnancy

Research highlights include: Skin Health : Promotes collagen and elastin synthesis, enhancing skin elasticity and firmness in experimental models

Newer drugs target more than one metabolic receptor, which may produce greater effects on weight and blood sugar

and Amano, I., 2000

You then avoid unwanted side effects that can occur from ingesting some oral supplements (i.e